Advertisement
Advertisement

ARTV

ARTV logo

Artiva Biotherapeutics, Inc. Common Stock

9.33
USD
Sponsored
+0.01
+0.11%
Jun 25, 10:06 UTC -4
Open

Artiva Biotherapeutics, Inc. Common Stock Profile

About

Artiva Biotherapeutics Inc. is a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers. The company's lead program includes AlloNK(R). Artiva Biotherapeutics Inc. is based in SAN DIEGO.

Info & Links

CEO

Fred Aslan

Headquarters

5505 MOREHOUSE DRIVE
SAN DIEGO, CA 92121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.artivabio.com

Auditor

KPMG LLP

Share holders

15

Employees

104

Artiva Biotherapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

453.33M

Enterprise Value

432.38M

Enterprise Value/EBITDA(ttm)

-4.83

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.52

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-60.22%

Return on Invested Capital(ttm)

-61.84%

Return on Assets(ttm)

-52.38%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-89.43M

Net Income Available to Common(ttm)

-87.07M

Diluted EPS(ttm)

-3.42

Share Statistics

Beta (5Y Monthly)

1.46

52-Week Change

479.50%

S&P 500 52-Week Change

20.45%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

24.72M

Dividend Yield

0.00%

Float4

19.43M

% Held by Insiders

21.40%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

86.78M

Total Cash Per Share(mrq)

3.51

Total Debt(mrq)

11.00K

Total Debt/Equity(mrq)

0.04%

Current Ratio(mrq)

8.61%

Quick Ratio(mrq)

8.61%

Book Value Per Share(mrq)

4.47

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.14

Free Cash Flow(ytd)

-79.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement